XML 38 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Income Statement [Abstract]        
Net sales $ 209,320 $ 195,619 $ 585,518 $ 545,248
Cost of sales 113,767 105,724 316,285 301,461
Gross profit 95,553 89,895 269,233 243,787
Operating expenses:        
Research and development and other engineering 9,711 9,226 29,505 27,018
Selling 23,592 20,630 69,623 63,654
General and administrative 29,557 28,523 85,993 82,906
Impairment of goodwill 492 0 492 [1] 0
Loss (gain) on sale of assets (17) 631 (336) 634
Total operating expenses 63,335 59,010 185,277 174,212
Income from operations 32,218 30,885 83,956 69,575
Interest (expense) income, net (27) (9) 44 32
Income before taxes 32,191 30,876 84,000 69,607
Provision for income taxes 11,577 10,870 30,849 26,304
Net income $ 20,614 $ 20,006 $ 53,151 $ 43,303
Earnings per common share:        
Basic (in dollars per share) $ 0.42 $ 0.41 $ 1.09 $ 0.89
Diluted (in dollars per share) $ 0.42 $ 0.41 $ 1.08 $ 0.89
Number of shares outstanding        
Basic (in shares) 49,010 48,377 48,972 48,482
Diluted (in shares) 49,227 48,551 49,172 48,603
Cash dividends declared per common share (in dollars per share) $ 0.14 $ 0.125 $ 0.405 $ 0.250
[1] See Note 1 "Basis of Presentation — Goodwill Impairment Testing"